Wei-Ting Chen Selected Research

tazobactam drug combination ceftolozane

4/2022	Activity of ceftolozane/tazobactam against Gram-negative isolates among different infections in Hong Kong: SMART 2017-2019.
1/2022	In vitro activity of ceftolozane/tazobactam against Gram-negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries-SMART 2017-2019.
1/2022	Ceftolozane/Tazobactam Activity Against Drug-Resistant Pseudomonas aeruginosa and Enterobacterales Causing Healthcare-Associated Infections in Eight Asian Countries: Report from an Antimicrobial Surveillance Program (2016-2018).
10/2019	Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Ting Chen Research Topics

Disease

42	Neoplasms (Cancer) 04/2024 - 09/2007
39	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2007
16	Infections 09/2023 - 05/2010
9	Alzheimer Disease (Alzheimer's Disease) 08/2023 - 03/2011
7	Fibrosis (Cirrhosis) 04/2024 - 05/2007
7	Chronic Hepatitis C 03/2022 - 10/2013
6	Neoplasm Metastasis (Metastasis) 07/2023 - 01/2018
6	Inflammation (Inflammations) 12/2021 - 12/2016
6	Myocardial Infarction 10/2021 - 05/2014
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2017
5	Heart Arrest (Cardiac Arrest) 12/2022 - 11/2015
5	Infarction (Infarctions) 10/2021 - 02/2015
4	Liver Diseases (Liver Disease) 04/2024 - 01/2017
4	Insulin Resistance 01/2024 - 01/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 01/2018
4	Hyperthermia 01/2023 - 01/2019
4	Sepsis (Septicemia) 04/2022 - 05/2007
4	Body Weight (Weight, Body) 12/2021 - 01/2014
3	Chronic Hepatitis B 02/2024 - 05/2010
3	Communicable Diseases (Infectious Diseases) 10/2023 - 02/2018
3	Carcinogenesis 01/2023 - 01/2017
2	Out-of-Hospital Cardiac Arrest 03/2024 - 01/2014
2	Cryoglobulinemia 01/2024 - 01/2021
2	Hepatitis C 01/2024 - 12/2020
2	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2023
2	Critical Illness (Critically Ill) 10/2023 - 01/2017
2	Tuberculosis (Tuberculoses) 10/2023 - 02/2020
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 09/2023 - 01/2022
2	Neuroinflammatory Diseases 01/2023 - 01/2017
2	COVID-19 01/2023 - 11/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2020
2	Heart Failure 01/2022 - 05/2014
2	Hepatitis 01/2022 - 01/2014
2	Cardiac Arrhythmias (Arrythmia) 10/2021 - 01/2021
2	Acute-On-Chronic Liver Failure 01/2021 - 12/2014
2	End Stage Liver Disease 01/2021 - 12/2014
2	Lung Neoplasms (Lung Cancer) 06/2020 - 02/2019
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2017
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 05/2014
2	Sarcopenia 10/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2012
7	InterferonsIBA 01/2024 - 10/2013
6	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2014
5	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 01/2014
5	BilirubinIBA 01/2023 - 04/2015
5	Amyloid (Amyloid Fibrils)IBA 01/2023 - 03/2011
4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
4	tazobactam drug combination ceftolozaneIBA 04/2022 - 10/2019
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2020 - 09/2018
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 11/2009
3	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 01/2023
3	atezolizumabIBA 01/2023 - 01/2022
3	VaccinesIBA 01/2023 - 02/2018
3	CalciumIBA 01/2023 - 01/2011
3	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2022
3	AlbuminsIBA 01/2023 - 01/2022
3	Particulate MatterIBA 11/2022 - 01/2019
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 08/2015
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2017
3	amentoflavoneIBA 03/2021 - 09/2017
3	hyperforinIBA 10/2020 - 01/2017
3	Antifungal AgentsIBA 06/2018 - 11/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 07/2015
2	Alanine Transaminase (SGPT)IBA 04/2024 - 01/2022
2	Alkaline PhosphataseIBA 04/2024 - 09/2023
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2023 - 01/2021
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 09/2023 - 01/2022
2	Imipramine (Janimine)FDA LinkGeneric 07/2023 - 01/2021
2	Fluoxetine (Prozac)FDA LinkGeneric 03/2023 - 02/2019
2	lenvatinibIBA 01/2023 - 01/2023
2	Propolis (Bee Bread)IBA 01/2023 - 09/2019
2	AntibodiesIBA 01/2023 - 01/2014
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2021
2	AutoantibodiesIBA 01/2022 - 06/2016
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2011
2	Connexin 43 (Connexin43)IBA 10/2021 - 01/2020
2	Nerve Growth Factor (NGF)IBA 01/2021 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2020
2	Neuroprotective AgentsIBA 01/2020 - 11/2018
2	Chlorogenic AcidIBA 01/2020 - 01/2019
2	Ribavirin (Virazole)FDA LinkGeneric 12/2019 - 10/2013
2	Superoxides (Superoxide)IBA 03/2019 - 02/2015
2	Protein CIBA 02/2019 - 01/2017
2	X-Linked Inhibitor of Apoptosis ProteinIBA 02/2019 - 01/2017

Therapy/Procedure

30	Therapeutics 04/2024 - 11/2011
15	Radiofrequency Ablation 10/2022 - 09/2007
7	Drug Therapy (Chemotherapy) 03/2021 - 12/2015
5	Electrodes (Electrode) 10/2023 - 01/2007
4	Cardiopulmonary Resuscitation (CPR) 03/2024 - 01/2014
4	Induced Hypothermia 12/2022 - 01/2020
3	Transplantation 06/2018 - 02/2015
3	Aftercare (After-Treatment) 01/2018 - 12/2014
2	Liver Transplantation 04/2024 - 05/2021
2	Resuscitation 03/2024 - 11/2015
2	Immunotherapy 12/2023 - 10/2015
2	Proton Therapy 03/2022 - 01/2018
2	Ablation Techniques 11/2021 - 09/2007
2	Radiotherapy 01/2020 - 11/2013